Acinetobacter spp. - A Serious Enemy Threatening Hospitals Worldwide

Open access

Acinetobacter spp. - A Serious Enemy Threatening Hospitals Worldwide

Acinetobacter is gram-negative, strictly aerobic bacteria. It is a heterogeneous group of organisms that is ubiquitous, widely distributed in nature. Surviving in hospital environment (they are able to survive on dry particles and dust up to ten days, more then four months on both moist and dry surfaces such as PVC, rubber, ceramics and various types of medical equipment) they are an important cause of infection in immunocompromised patients. A. baumannii, the major cause of intrahospital infections, exhibits a remarkable ability to rapidly develop antibiotic resistance to several classes of antimicrobial agents that led to MDRA, or to almost all currently available antibacterial agents, except to polymixins. There is an increasing incidence of these infections in hospital intensive care units. The prevalence currently ranges from 2% to 10% of all gram-negative bacterial infections in Europe and about 2.5% of them in the United States. Good treatment choice, combined with infection control measures should help in preventing intrahospital spread of multiresistant strains of Acinetobacter spp. Nevertheless, their adaptation mechanisms to antibiotic selection pressure suggest that this problem will continue into the future.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Dijkshoorn L van Aken E Shunburne L van der Reijden TJK Bernards AT Nemes A Towner KJ. Prevalence of Acinetobacter baumannii and other Acinetobacter spp. in faecal samples from non-hospitalised individuals. Clinc Microbiol Infect. 2005;11:329-332. doi:10.1111/j.1469-0691.2005.01093.xPMID:15760432

  • Mandel AD Wright K McKinnon M. Selective medium for isolation of Mima and Herellea organisms. J Bacteriol. 1964;88:1524-1525. PMID:14234815

  • Jawad A Hawkey PM Hertage J Snelling AM. Description of Leeds Acinetobacter Medium a new selective and differential medium for isolation of clinically important Acinetobacter spp. and comparison with Herellea agar and Holton's agar. J Clinc Microbiol 1994;32(10):2353-2358. PMID:7814465

  • Seifert H Dijkshoorn L Gerner-Smidt P Pelzer N Tjernberg I Vaneechoutte M. Distribution of Acinetobacter species on human skin: Comparison of phenotypic and genotypic identification methods. J Clin Microbiol. 1997;35(11):2819-2825. PMID:9350741

  • Larson E L. Persistent carriage of gram-negative bacteria on hands. Am J Infect Control. 1981;9: 112-119. doi:10.1016/S0196-6553(81)80091-0PMID:10283847

  • Webster C Towner KJ Humphreys H. Survival of Acinetobacter on three clinically related inanimate surfaces. Infect Control Hosp Epidemiol. 2000;21:246. doi:10.1086/503214PMID:10782579

  • Wendt C Dietze B Dietz E Ruden H. Survival of Acinetobacter baumannii on dry surfaces. J Clinic Microbiol. 1997;35(6):1394-1397. PMID:9163451

  • Ng PC Herrington RA Beane CA Ghoneim AT Dear PR. An outbreak of Acinetobacter septicaemia in neonatal intensive care unit. J Hosp Infect. 1989;14:363-368. doi:10.1016/0195-6701(89)90077-7PMID:2575636

  • Stone JW Das BC. Investigation of an outbreak of infection with Acinetobacter calcoaceticus in a special care baby unit. J Hosp Infect. 1986;7(1):42-48. PMID:2870108

  • Boujaafar N Freney J Bouvet PJ Jeddi M. Cell suface hydrophobicity of 88 clinical strains of Acinetobacter baumannii. Research in Microbiology. 1990;141:477-82. doi:10.1016/0923-2508(90)90073-YPMID:2399369

  • Kaplan N Rosenberg E Jann B Jann K. Structural studies of the capsular polysaccharide of Acinetobacter calcoaceticus BD4. Eur J Biochem. 1985;152:453-458. doi:10.1111/j.1432-1033.1985.tb09218.xPMID:4054115

  • Rosenberg E Kaplan N Pines O Rosenberg M Gutnick D. Capsular polysaccharides interfere with adherence of Acinetobacter calcoaceticus to hydrocarbon. FEMS Microbiol Lett. 1983;17:157-160. doi:10.1111/j.1574-6968.1983.tb00392.x

  • Poh CL Loh GK. Enzymatic profile of clinical isolates of Acinetobacter calcoaceticus. Med Microbiol Immunol. 1985;174:29-33. doi:10.1007/BF02123668PMID:4000064

  • Echenique JR Arineti H Tomasky ME Read RR Staneloni RJ Crosa JH Actis LA. Characterization of highaffinity iron transport system in Acinetobacter baumannii. J Bacteriol. 1992;174(23):7670-7679. PMID:1447137

  • Smith AW Freeman S Minett WG Lambert PA. Characterization of a siderophore from Acinetobacter calcoaceticus. FEMS Microbiol Lett. 1990;70:29-32. doi:10.1111/j.1574-6968.1990.tb03771.x

  • Avril JL Mesnard R. Factors influencing the virulence of Acinetobacter p. 77-82 In Towner KJ Bergogne-Berezin E Fewson CA. The biology of Acinetobacter. Plenum Publishing Corp: New York 1991.

  • Obana Y. Patogenic significance of Acinetobacter calcoaceticus: analysis of experimental infection in mice. Microbiol Immunol. 1986;30(7):645-657. PMID:3773789

  • Bergogne-Berezin E Towner KJ. Acinetobacter spp as nosocomial pathogens: microbiological clinical and epidemiological features. Clin Microbiol Rev. 1996;9(2):148-165. PMID:8964033

  • Van Looveren M Goossens H. Antimicrobial resistance of Acinetobacter spp in Europe. Clin Microbiol Infect. 2004;10:684-704. doi:10.1111/j.1469-0691.2004.00942.xPMID:15301671

  • Go ES Urban C Burns J et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet. 1994;334(8933):1329-1332. doi:10.1016/S0140-6736(94)90694-7PMID:7968028

  • Towner KJ Vivian A. Plasmids capable of transfer and chromosome mobilisation in Acinetobacter calcoaceticus. J Gen Microbiol. 1977;101:167-171.

  • Seifert H Boullion B Schulze A Pulverer G. Plasmid DNA profiles of Acinetobacter baumannii: Clinical application in a complex endemic setting. Infect Control Hosp Epidemiol. 1994;15(8):520-528. PMID:7983345

  • Devaud M Kayser FH Bchi B. Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother. 1982;22:323-329. PMID:6100428

  • Segal H Thomas R Gay EB. Characterisation of class I resistance gene cassettes and the identification of a novel IS-like element in Acinetobacter baumannii. Plasmid. 2003;49:169-178. doi:10.1016/S0147-619X(03)00011-8PMID:12726770

  • Poirel L Menuteau O Agoli N Cattoen C Nordmann P. Outbreak of extended-spectrum beta-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol. 2003;41:3542-3547. doi:10.1128/JCM.41.8.3542-3547.2003PMID:12904353

  • Koljalg S Naaber P Mikelsaar M. Antibiotic resistance as an indicator of bacterial chlorxedine susceptibility. J Hosp Infect. 2002;51:106-113. doi:10.1053/jhin.2002.1204PMID:12090797

  • Fournier PE Vallenet D Barbe V Audic S Ogata H et al. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2006;2(1):e7. doi:10.1371/journal.pgen.0020007PMID:16415984

  • Rossolini GM et al. Epidemiology of infections caused by multiresistant Gram-negatives: ESBLs MBLs panresistant strains. New Microbiologica. 2007;30(3):332-339. PMID:17802921

  • Seifert H Strate A Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii: clinical features epidemiology and predictor of mortality. Medicine (Baltimore). 1995;74:340-349. doi:10.1097/00005792-199511000-00004PMID:7500897

  • Villers D Espaze E Coste-Burel M Giauffret F Ninin E Nicolas F Richet H. Nosocomial Acinetobacer baumannii infections: microbiological and clinical epidemiology. Ann Intern Med. 1998;129(3):182-189. PMID:9696725

  • Bernards AT Frenay HM Lim BT Hendrics WD Dijkshoorn L van Boven CP. Methicillin-resistant Stahylococcus aureus and Acinetobacter baumannii: an unexpected difference in epidemiologic behaviour. Am J Infect Control. 1998;26:544-551. doi:10.1053/ic.1998.v26.a84555PMID:9836836

  • Hanberger H Gracia Rodrigues JA Gobernado M Goossens H Nilsson LE et al. Antibiotic susceptibility among aerobic gram-negative bacilli in intensive care units in 5 European countries. French and Portuguese ICU Study Groups. JAMA. 1999;281:67-71 doi:10.1001/jama.281.1.67PMID:9892453

  • Jones ME Draghi DC Thornsberry C Karlowsky JA Sahm DF et al. Emerging resistance among bacterial pathogens in the intensive care unit - A European and North American Surveillance study (2000-2002). Ann Clin Microbiol Antimicrob. 2004;3:14. doi:10.1186/1476-0711-3-14PMID:15283864

  • Hartstein AI Rashad AL Leibler JM et al. Multiple intensive care units outbreak of Acinetobacter calcoaceticus subspecies anitratus respiratory infection and colonization associated with contaminated reusable ventilator circuits and rescuciation bags. Am J Med. 1998;85(5):624-631. PMID:3189366

  • Beck-Sague CM JarvisWR Bland LA Arduing MJ Aguero SM Verosic G. Outbreak of gram-negative bacteremia and pyrogeic reactions in a hemodialysis center. Am J Nephrol. 1990;10(5):397-403. doi:10.1159/000168155PMID:2080790

  • Weernink A Severin WP Tjernberg I Dijkshoorn L. Pillows an unexpected souse of Acinetobacter. J Hosp Infect. 1995;29:189-199. doi:10.1016/0195-6701(95)90328-3PMID:7615936

  • Patterson JE Vecchio J Pantelick EL et al. Association of contaminated glowes with transmission of Acinetobacter calcoaceticus var. anitratus in an intensive care unit. Am J Med. 1991;91:479-483. doi:10.1016/0002-9343(91)90183-XPMID:1951409

  • Simor AE Lee M Vearncombe M et al. An outbreak due to multiresitant Acinetobacter baumannii in a burn unit: risk factors for acquisition and management Infect Control Hosp Epidemiol. 2002;23:261-267. doi:10.1086/502046PMID:12026151

  • Torres A Aznar R Gatell JM Jiminez P Gonzales J Ferrer A Celis R Rodrigues-Roisin R. Incidence risk and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 1990;142(3):522-528. PMID:2202245

  • Siegman-Igra Y Bar Yosef S Gorea A Avram J. Nosocomila Acinetobacter meningitis secondary to invasive procedures: report of 25 cases and review. Clin Infect Dis. 1993;17:843-849. PMID:8286623

  • Pedraza F Andreu A Saune M Moreno A Ramirez L Garcia L. A urinary outbreak of Acinetobacter baumannii in a spinal cord injury unit. Ann Med Interna. 1993;10(2):55-58. PMID:8452972

  • Nemec A Janda L Melter O Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol. 1999;48: 287-296. doi:10.1099/00222615-48-3-287PMID:10334596

  • Grundmann HJ Towner KJ Dijkshoorn L et al. Multicenter study using standarzied protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Cinic Microbiol. 1997;35(12):3071-3077. PMID:9399496

  • Levin AS Mendes CM Sinto SI et al. An outbreak of multiresistant Acinetobacter baumannii in a university hospital in Sao Paulo Brazil. Infect Control Hosp Epidemiol. 1996;17:366-368. PMID:8805068

  • Siau H Yuen KY Ho PL Wong SS Woo PC. Acinetobacter bacteremia in Hong Kong: prospective study and review. Clin Infec Dis. 1999;28:26-30. doi:10.1086/515068PMID:10028065

  • Dijkshoorn L Aucken H Gerner-Smidt P. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol. 1996;34(6):1519-25. PMID:8735109

  • Vila J Ruiz J Navia M. Spread of amikacin resistance in Acinetobacter baumannii strains isolated in Spain due to epidemic strain. J Clin Microbiol. 1999;37(3):758-61. PMID:9986846

  • Munoz-Price LS Weinstein RA. Acinetobacter infection. The New Eng J Med. 2008;358:1271-1281. doi:10.1056/NEJMra070741PMID:18354105

  • Buosson Y Tran van Nhieu G Ginot L Bouvet P Schill H Driot L. Nosocomial outbreaks due to amikacin-resistant tobramycin-sensitive Acinetobacter species: correlation with amikacin usage. J Hosp Infect. 1990;15:83-93. doi:10.1016/0195-6701(90)90024-IPMID:1968483

  • Leonov Y Schlaeffer F Karpuch J Bourvin A Shemesh Y Lewinson G. Ciprofloxacin in the treatment of nosocomial multiply resistant Acinetobacter calcoaceticus bacteremia. Infection. 1990;18:234-236. doi:10.1007/BF01643395PMID:2210856

  • Jain R Dnaziger LH. Multi-resistant acinetobacter infections: an emerging challenge to physicians. Ann Pharmacother. 2004;38:1449-1459. doi:10.1345/aph.1D592PMID:15280512

  • Clark NM Patterson JP Lynch III. Antimicrobial resistance among gram-negative organism in an intensive care unit. Curr Opin Crit Care. 2003;9:413-423. doi:10.1097/00075198-200310000-00012PMID:14508155

Journal information
Impact Factor

CiteScore 2016: 0.16

SCImago Journal Rank (SJR) 2016: 0.136
Source Normalized Impact per Paper (SNIP) 2016: 0.141

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 231 132 4
PDF Downloads 117 66 0